BTIG Maintains a Buy Rating on Stryker (SYK)

In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Stryker (SYKResearch Report), with a price target of $244.00. The company’s shares closed last Tuesday at $204.41.

According to TipRanks.com, Zimmerman is a 4-star analyst with an average return of 7.1% and a 45.0% success rate. Zimmerman covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Treace Medical Concepts, and Zimmer Biomet Holdings.

Currently, the analyst consensus on Stryker is a Moderate Buy with an average price target of $253.24, representing a 25.0% upside. In a report issued on July 12, Nephron also initiated coverage with a Buy rating on the stock with a $240.00 price target.

See today’s best-performing stocks on TipRanks >>

Based on Stryker’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $4.28 billion and net profit of $323 million. In comparison, last year the company earned revenue of $3.95 billion and had a net profit of $302 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Michigan-based Stryker Corp. was founded in 1941. The company provides medical technology products and services. It operates its business through the following segments: Orthopaedics, MedSurg and Neurotechnology and Spine.

Read More on SYK:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More